All In MedTech

Device Trial Radar · NCT05932602

AVEIR DR Coverage With Evidence Development (CED) Study

The AVEIR DR Coverage With Evidence Development (DRIVE) Study

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

2,812

Planned (sponsor's estimate)

Start

Oct 31, 2023

Primary completion

May 2029

Study completion May 2030

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jul 6, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the dual chamber Aveir Leadless Pacemaker device (aka Aveir™ DR LP system).

Conditions

  • Cardiac Pacemaker
  • Arrythmia
  • Bradycardia

Interventions

  • Aveir DR Leadless Pacemaker SystemDevice

    This study will utilize real-world data from patients implanted with the Aveir DR Leadless Pacemaker System. No device intervention is required in this study.

  • Dual Chamber Transvenous PacemakerDevice

    This study will utilize real-world data from patients implanted with a dual-chamber transvenous pacemaker as a comparator to the Aveir DR LP system study arm. No device intervention is required in this study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acute device related complication rateTime frame: 30 days
  2. Two-year survival rateTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Abbott

    Sylmar, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.